Pulmonary diseases associated with inflammatory bowel diseases

被引：40

作者：

Casella, Giovanni

Villanacci, Vincenzo ^{[2
]}

Di Bella, Camillo ^{[1
]}

Antonelli, Elisabetta ^{[3
]}

Baldini, Vittorio

Bassotti, Gabrio ^{[3
]}

机构：

[1] Desio Gen Hosp, Pathol Unit, Desio, Italy

[2] Spedali Civili Brescia, Pathol Sect 2, Brescia, Italy

[3] Univ Perugia, Dept Clin & Expt Med, Gastroenterol & Hepatol Sect, I-06100 Perugia, Italy

来源：

JOURNAL OF CROHNS & COLITIS | 2010年 / 4卷 / 04期

关键词：

Crohn's disease; Inflammatory bowel diseases; Lung pathology; Ulcerative colitis; CROHNS-DISEASE; ESOPHAGOBRONCHIAL FISTULA; LUNG-DISEASE; RISK-FACTORS; EXTRAINTESTINAL MANIFESTATIONS; HYPERSENSITIVITY REACTION; OPPORTUNISTIC INFECTIONS; VASCULAR COMPLICATIONS; INFLIXIMAB TREATMENT; VENOUS THROMBOSIS;

D O I：

10.1016/j.crohns.2010.02.005

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Among the extra-intestinal manifestations of inflammatory bowel diseases, those involving the lung are relatively rare. However, there is a wide array of such manifestations, spanning from drug-related pathologies to airway disease, fistulas, granulomatous diseases, autoimmune and thromboembolic disorders. Although infrequent, people dealing with inflammatory bowel diseases must be aware of these conditions, sometimes life-threatening, to avoid further impairment of the health status of the patients and to alleviate their symptoms by prompt recognition and treatment. (C) 2010 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

引用

页码：384 / 389

页数：6

共 86 条

[1] Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease [J].